Publication Information

{'id': 'https://openalex.org/W1986632087', 'doi': 'https://doi.org/10.1191/1078155204jp138oa', 'title': 'Temozolomide for malignant gliomas in British Columbia: A population-based cost-effectiveness analysis', 'display_name': 'Temozolomide for malignant gliomas in British Columbia: A population-based cost-effectiveness analysis', 'publication_year': 2004, 'publication_date': '2004-12-01', 'ids': {'openalex': 'https://openalex.org/W1986632087', 'doi': 'https://doi.org/10.1191/1078155204jp138oa', 'mag': '1986632087'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1191/1078155204jp138oa', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S66425452', 'display_name': 'Journal of Oncology Pharmacy Practice', 'issn_l': '1078-1552', 'issn': ['1078-1552', '1477-092X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5060356887', 'display_name': 'ED Greanya', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I141945490', 'display_name': 'University of British Columbia', 'ror': 'https://ror.org/03rmrcq20', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I141945490']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'ED Greanya', 'raw_affiliation_strings': ['University of British Columbia, BC, Canada'], 'affiliations': [{'raw_affiliation_string': 'University of British Columbia, BC, Canada', 'institution_ids': ['https://openalex.org/I141945490']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019903105', 'display_name': 'S. Martin Taylor', 'orcid': 'https://orcid.org/0000-0001-8880-5417'}, 'institutions': [{'id': 'https://openalex.org/I1289530486', 'display_name': 'BC Cancer Agency', 'ror': 'https://ror.org/03sfybe47', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289530486']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'SCM Taylor', 'raw_affiliation_strings': ['British Columbia Cancer Agency (BCCA) Provincial Pharmacy Program, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6'], 'affiliations': [{'raw_affiliation_string': 'British Columbia Cancer Agency (BCCA) Provincial Pharmacy Program, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6', 'institution_ids': ['https://openalex.org/I1289530486']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017748352', 'display_name': 'F Hu BscPharm', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1289530486', 'display_name': 'BC Cancer Agency', 'ror': 'https://ror.org/03sfybe47', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289530486']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'F Hu BscPharm', 'raw_affiliation_strings': ['British Columbia Cancer Agency (BCCA) Provincial Pharmacy Program, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6'], 'affiliations': [{'raw_affiliation_string': 'British Columbia Cancer Agency (BCCA) Provincial Pharmacy Program, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6', 'institution_ids': ['https://openalex.org/I1289530486']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103017897', 'display_name': 'Jeff Barnett', 'orcid': 'https://orcid.org/0009-0003-8193-7419'}, 'institutions': [{'id': 'https://openalex.org/I1289530486', 'display_name': 'BC Cancer Agency', 'ror': 'https://ror.org/03sfybe47', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289530486']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'J Barnett', 'raw_affiliation_strings': ['British Columbia Cancer Agency (BCCA) Provincial Pharmacy Program, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6'], 'affiliations': [{'raw_affiliation_string': 'British Columbia Cancer Agency (BCCA) Provincial Pharmacy Program, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6', 'institution_ids': ['https://openalex.org/I1289530486']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5031271840', 'display_name': 'Brian Thiessen', 'orcid': 'https://orcid.org/0000-0003-0752-6673'}, 'institutions': [{'id': 'https://openalex.org/I1289530486', 'display_name': 'BC Cancer Agency', 'ror': 'https://ror.org/03sfybe47', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289530486']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'B Thiessen', 'raw_affiliation_strings': ['Division of Medical Oncology, British Columbia Cancer Agency (BCCA), 600 West 10th Avenue, Vancouver, BC, V5Z 4E6 Canada'], 'affiliations': [{'raw_affiliation_string': 'Division of Medical Oncology, British Columbia Cancer Agency (BCCA), 600 West 10th Avenue, Vancouver, BC, V5Z 4E6 Canada', 'institution_ids': ['https://openalex.org/I1289530486']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.408, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.652855, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 74, 'max': 76}, 'biblio': {'volume': '10', 'issue': '4', 'first_page': '201', 'last_page': '209'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10129', 'display_name': 'Gliomas', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10129', 'display_name': 'Gliomas', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11251', 'display_name': 'Epidemiology and Treatment of Meningiomas', 'score': 0.9935, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12108', 'display_name': 'Management of Spinal Metastatic Tumors', 'score': 0.9865, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lomustine', 'display_name': 'Lomustine', 'score': 0.9542466}, {'id': 'https://openalex.org/keywords/progression-free-survival', 'display_name': 'Progression-free survival', 'score': 0.5820842}, {'id': 'https://openalex.org/keywords/dacarbazine', 'display_name': 'Dacarbazine', 'score': 0.50753033}, {'id': 'https://openalex.org/keywords/temozolomide', 'display_name': 'Temozolomide', 'score': 0.507349}], 'concepts': [{'id': 'https://openalex.org/C2777389519', 'wikidata': 'https://www.wikidata.org/wiki/Q425088', 'display_name': 'Temozolomide', 'level': 3, 'score': 0.9845517}, {'id': 'https://openalex.org/C2779434656', 'wikidata': 'https://www.wikidata.org/wiki/Q415378', 'display_name': 'Lomustine', 'level': 5, 'score': 0.9542466}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.92595536}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5881963}, {'id': 'https://openalex.org/C2780739268', 'wikidata': 'https://www.wikidata.org/wiki/Q2112244', 'display_name': 'Progression-free survival', 'level': 3, 'score': 0.5820842}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.5154832}, {'id': 'https://openalex.org/C2780964509', 'wikidata': 'https://www.wikidata.org/wiki/Q416975', 'display_name': 'Dacarbazine', 'level': 3, 'score': 0.50753033}, {'id': 'https://openalex.org/C2778227246', 'wikidata': 'https://www.wikidata.org/wiki/Q1365309', 'display_name': 'Glioma', 'level': 2, 'score': 0.4993589}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.4824246}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4711377}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.42172393}, {'id': 'https://openalex.org/C2779429289', 'wikidata': 'https://www.wikidata.org/wiki/Q408977', 'display_name': 'Vincristine', 'level': 4, 'score': 0.17142189}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.058296353}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1191/1078155204jp138oa', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S66425452', 'display_name': 'Journal of Oncology Pharmacy Practice', 'issn_l': '1078-1552', 'issn': ['1078-1552', '1477-092X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 18, 'referenced_works': ['https://openalex.org/W1795588153', 'https://openalex.org/W1843279041', 'https://openalex.org/W1963744937', 'https://openalex.org/W1974210709', 'https://openalex.org/W1977392502', 'https://openalex.org/W1993808515', 'https://openalex.org/W2025470807', 'https://openalex.org/W2081013010', 'https://openalex.org/W2086015324', 'https://openalex.org/W2106649727', 'https://openalex.org/W2108627867', 'https://openalex.org/W2113647927', 'https://openalex.org/W2114753552', 'https://openalex.org/W2125643269', 'https://openalex.org/W2148549004', 'https://openalex.org/W2182271449', 'https://openalex.org/W2264385870', 'https://openalex.org/W4231637567'], 'related_works': ['https://openalex.org/W4313656783', 'https://openalex.org/W4309018543', 'https://openalex.org/W4237783004', 'https://openalex.org/W2916546025', 'https://openalex.org/W2374912696', 'https://openalex.org/W2304205254', 'https://openalex.org/W2078219238', 'https://openalex.org/W2072545223', 'https://openalex.org/W2070226426', 'https://openalex.org/W1986632087'], 'abstract_inverted_index': {'Study': [0], 'objectives.': [1], 'To': [2], 'evaluate': [3], 'the': [4, 28, 106, 144, 192, 208, 298], 'cost-effectiveness': [5, 193], 'and': [6, 32, 46, 85, 87, 101, 108, 116, 123, 129, 131, 204, 235, 284], 'outcomes': [7, 138, 253, 283], 'achieved': [8], 'in': [9, 18, 27, 99, 105, 239, 252, 297], 'patients': [10, 59, 104, 128, 153, 175, 224, 257], 'with': [11, 16, 149, 163, 182, 259], 'recurrent': [12, 302], 'malignant': [13, 303], 'glioma': [14], 'treated': [15, 258], 'temozolomide': [17, 34, 63, 107, 127, 152, 198, 215, 242], 'British': [19], 'Columbia,': [20], 'as': [21], 'compared': [22], 'to': [23, 33, 57, 246], 'previous': [24], 'lomustine': [25, 65, 109, 135, 174, 261, 272, 290], 'use': [26], 'same': [29], 'patient': [30, 168, 187], 'population,': [31], 'literature': [35], 'reports.': [36], 'Outcomes': [37], 'assessed': [38], 'included': [39], 'median': [40, 117, 156, 165, 178, 184, 196, 233], 'overall': [41, 44, 114, 118], 'survival,': [42, 75], '6-month': [43, 47, 206, 236], 'survival': [45, 96, 115, 119, 282], 'progression': [48, 94, 225], 'free': [49, 95, 226], 'survival.': [50], 'Methods.': [51], 'A': [52], 'retrospective': [53], 'analysis': [54, 194, 230], 'was': [55, 72, 199, 216], 'conducted': [56], 'identify': [58], 'who': [60], 'received': [61, 154, 176], 'single-agent': [62, 260], 'or': [64, 89, 262], 'during': [66], 'successive,': [67], 'prespecified': [68], 'time': [69], 'periods.': [70], 'Data': [71], 'collected': [73], 'on': [74], 'disease': [76], 'progression,': [77], 'duration': [78], 'of': [79, 82, 103, 157, 160, 169, 179, 188, 214, 223, 241, 273, 301], 'therapy,': [80], 'cost': [81, 166, 185, 210, 269], 'drug,': [83], 'labour': [84], 'supplies,': [86], 'successive': [88], 'prior': [90], 'chemotherapy.': [91], 'Results.': [92], 'Six-month': [93, 113], '(PFS)': [97], 'occurred': [98], '52%': [100], '42.9%': [102], 'cohorts,': [110], 'respectively': [111], '(P=0.44).': [112], '(OS)': [120], 'were': [121, 139, 254], '72%': [122], '40.86': [124], 'weeks': [125, 133], 'for': [126, 134, 195, 205, 219], '64.3%': [130], '46.7': [132], 'patients.': [136], 'These': [137], 'not': [140, 200], 'statistically': [141], 'different': [142], 'between': [143, 256], 'two': [145], 'treatment': [146, 286, 295], 'groups.': [147], 'Associated': [148], 'these': [150], 'outcomes,': [151], 'a': [155, 164, 177, 183, 201, 292], 'six': [158], 'cycles': [159, 181], 'drug': [161], 'treatment,': [162], 'per': [167, 186, 276], '$11': [170, 274], '660': [171], '(CAN).': [172, 190], 'Alternatively,': [173], 'four': [180], '$189': [189], 'In': [191], 'OS,': [197], 'cost-effective': [202, 294], 'alternative,': [203], 'PFS,': [207], 'incremental': [209, 268], 'effectiveness': [211], 'ratio': [212], '(ICER)': [213], '$1261': [217], '(CAN)': [218], 'each': [220], 'additional': [221], 'percent': [222], 'at': [227], '6-months.': [228], 'Sensitivity': [229], 'varying': [231], 'both': [232], 'OS': [234], 'PFS': [237], 'resulted': [238], 'ICER’s': [240], 'ranging': [243], 'from': [244], '$332': [245], '$3277.': [247], 'Conclusions.': [248], 'No': [249], 'significant': [250], 'differences': [251], 'observed': [255], 'temozolomide.': [263], 'Temozolomide': [264], 'therapy': [265], 'has': [266], 'an': [267], 'increase': [270], 'over': [271], '471': [275], 'patient.': [277], 'It': [278], 'appears': [279], 'when': [280], 'only': [281], 'direct': [285], 'costs': [287], 'are': [288], 'considered,': [289], 'is': [291], 'more': [293], 'strategy': [296], 'specific': [299], 'setting': [300], 'glioma.': [304]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1986632087', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-09-26T19:02:17.719111', 'created_date': '2016-06-24'}